Related Experiment Video
Updated: Jan 27, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Long noncoding RNA CASC11 promotes osteosarcoma metastasis by suppressing degradation of snail mRNA
Kaifang Song1, Xiang Yuan2,3, Guifang Li1
1Department of Pulmonary Tumor Surgery, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology Luoyang 471003, Henan Province, China.
Abstract:
Osteosarcoma (OS) is the most common primary bone tumor in adolescents. Dysregulation of long noncoding RNAs (lncRNAs) is associated with the cancer progression, of which cancer susceptibility candidate 11 (CASC11) has been indicated as an oncogene in several human cancers. However, the underlying mechanisms by which CASC11 contributes to OS metastasis remain undetermined. Here, we found that CASC11 expression in OS tissues was markedly higher than that in noncancerous tissues. Clinical association analysis revealed that high CASC11 expression correlated with clinical stage, distant metastasis and poor prognosis of OS patients. Gain- and loss-of-function assays demonstrated that CASC11 promoted migration, invasion, epithelial-mesenchymal transition (EMT) and metastasis of OS cells in vitro and in vivo. CASC11 associated with the EMT inducer Snail mRNA and increased its stability. Association of CASC11 with Snail mRNA blocked the repressing effect of miR-122, miR-145, miR-211, miR-34a and miR-137 on Snail. Moreover, CASC11-specific siRNAs significantly inhibit tumor metastasis in vivo. Taken together, our findings suggest that CASC11 may be a candidate prognostic biomarker and a novel therapeutic target for OS.
Insights
Cancer susceptibility candidate 11 (CASC11) promotes osteosarcoma (OS) metastasis by stabilizing Snail mRNA. Targeting CASC11 may offer a new therapeutic strategy for OS patients with poor prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma (OS) is a prevalent bone cancer in adolescents.
- Long noncoding RNAs (lncRNAs) are implicated in cancer progression, with CASC11 identified as an oncogene in various cancers.
- The role of CASC11 in OS metastasis is not fully understood.
Purpose of the Study:
- To investigate the role and mechanism of CASC11 in osteosarcoma metastasis.
- To explore CASC11 as a potential prognostic biomarker and therapeutic target for OS.
Main Methods:
- Quantitative analysis of CASC11 expression in OS tissues and correlation with clinical data.
- In vitro and in vivo gain- and loss-of-function assays to assess CASC11's impact on OS cell behavior.
- Investigation of CASC11's interaction with Snail mRNA and microRNAs (miRNAs).
- Evaluation of CASC11-specific siRNAs in inhibiting tumor metastasis.
Main Results:
- CASC11 expression is significantly elevated in OS tissues compared to noncancerous tissues.
- High CASC11 expression correlates with advanced clinical stage, distant metastasis, and poor prognosis in OS patients.
- CASC11 promotes OS cell migration, invasion, epithelial-mesenchymal transition (EMT), and metastasis both in vitro and in vivo.
- CASC11 enhances Snail mRNA stability, thereby inhibiting the repressive effects of specific miRNAs (miR-122, miR-145, miR-211, miR-34a, miR-137) on Snail.
- CASC11-specific siRNAs effectively inhibit tumor metastasis in vivo.
Conclusions:
- CASC11 plays a crucial role in promoting osteosarcoma metastasis through Snail mRNA stabilization.
- CASC11 represents a potential prognostic biomarker for OS.
- CASC11 emerges as a promising novel therapeutic target for osteosarcoma.
More Related Videos
Related Concept Videos
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Nuclear Export of mRNA
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Stability

